DEF 14A

Company

SELLAS Life Sciences Group, Inc.

Filed

April 30, 2018

Period of Report

June 12, 2018

Accession Number

0001193125-18-143932

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →